Kaken Pharmaceutical Co's total assets for Q1 2025 were ¥174.78B, an increase of 1.84% from the previous quarter. JP:4521 total liabilities were ¥32.26B for the fiscal quarter, a 15.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.